drugset / Trial / NCT01684306

Pharmacological Cognitive Enhancement

NCT01684306

RandomizedParallel-groupDouble-blindSupportive care

Summary

There is growing debate on the use of drugs that can promote cognitive enhancement. Amphetamine-like drugs have been employed as cognitive enhancers, but all of them have important side effects and may induce addiction. In our study, we will investigate the use of modafinil which, in recent years, has been proposed as cognitive enhancer. Modafinil appears to have less side effects compared to amphetamine-like drugs and we will analyzed whether the drug can influence cognitive performances and the brain resting state network activity of healthy young subjects.

Timeline

Start
2011-02
Primary completion
2011-04
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 100 mg

Indications

No indication recorded.